Integra LifeSciences Holdings Corporation (IART)

Market Cap	4.98B
Revenue (ttm)	1.57B
Net Income (ttm)	172.99M
Shares Out	83.52M
EPS (ttm)	2.06
PE Ratio	28.94
Forward PE	16.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	373,124
Open	59.92
Previous Close	60.49
Day's Range	58.91 - 60.65
52-Week Range	40.67 - 68.29
Beta	1.13
Analysts	Buy
Price Target	59.57 (-0.07%)
Earnings Date	Feb 22, 2023

About IART

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumenta...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 16, 1995
• Employees: 3,800
• Stock Exchange: NASDAQ
• Ticker Symbol: IART

Financial Performance

In 2021, IART's revenue was $1.54 billion, an increase of 12.43% compared to the previous year's $1.37 billion. Earnings were $169.08 million, an increase of 26.28%.

Analyst Forecast

According to 20 analysts, the average rating for IART stock is "Buy." The 12-month stock price forecast is $59.57, which is a decrease of -0.07% from the latest price.

Price Target

$59.57

(-0.07% downside)

Analyst Consensus: Buy